Clinical

Dataset Information

0

Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal Origin


ABSTRACT: Intraoperative tumor localization and resection can be enhanced using intraoperative fluorescence imaging and radiodetection. Labetuzumab specifically recognizes CEA which is is expressed on > 95% of colorectal cancers.. Therefore Indium-111-DOTA-labetuzumab-IRDye800CW is a perfect dual-labeled antibody for dual-modality image-guided surgery in peritoneal carcinomatosis of colorectal cancer.

DISEASE(S): Peritoneal Neoplasms,Carcinoma,Gastrointestinal Neoplasms,Colorectal Cancer,Gastrointestinal Cancer,Neoplasms,Peritoneal Carcinomatosis

PROVIDER: 2286305 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 18348 | ecrin-mdr-crc
| 2069242 | ecrin-mdr-crc
2020-08-12 | GSE60668 | GEO
2020-08-12 | GSE60667 | GEO
2008-11-22 | E-GEOD-13147 | biostudies-arrayexpress
2008-11-15 | GSE13147 | GEO
| 2307077 | ecrin-mdr-crc
| PRJNA640831 | ENA
2023-03-27 | GSE227990 | GEO
2012-04-12 | E-GEOD-25338 | biostudies-arrayexpress